Key result
The provided text only contains the editorial board information and lacks the actual study data to determine the effects of metformin and pioglitazone on IL-6 and IL-8 in PCOS.
Why the study?
Elevated inflammatory mediators in PCOS reflect low-grade chronic inflammation associated with insulin resistance, suggesting insulin-sensitizing agents may improve reproductive and metabolic aspects.
Does the combination of metformin and pioglitazone improve inflammatory biomarkers and insulin resistance more than metformin alone in women with PCOS?
Comparison
Metformin (500 mg BD) plus pioglitazone (15 mg BD) vs metformin (500 mg BD) alone
Design
Randomized clinical trial
Follow-up
12 wks
Authors
Loading...
Combination therapy offers superior IL-6 reduction in PCOS; confirms additive anti-inflammatory and insulin-sensitizing effects over monotherapy.
RCT
Does the combination of metformin and pioglitazone improve inflammatory biomarkers and insulin resistance more than metformin alone in women with PCOS?
The combination of metformin and pioglitazone is more effective than metformin alone in reducing IL-6 levels and insulin resistance in women with PCOS.
Ali et al. (2019) conducted an RCT in Polycystic Ovary Syndrome. Metformin plus Pioglitazone vs. Metformin was evaluated on Serum Levels of IL-6 and IL-8. The provided text only contains the editorial board information and lacks the actual study data to determine the effects of metformin and pioglitazone on IL-6 and IL-8 in PCOS.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: